PCA Investment Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
PCA Investment Advisory Services's VRTX Position: Q3 2023 in Review
PCA Investment Advisory Services sold out of Vertex Pharmaceuticals (VRTX) in Q3 2023, closing a stake of 112 shares — an estimated $39.4K sold.
PCA Investment Advisory Services first reported a position in VRTX in Q2 2023 and held it in 1 quarter. The position peaked at $39.4K in Q2 2023. 1,277 funds tracked by Wall St. Rank hold VRTX as of Q3 2023.
- PCA Investment Advisory Services reported no remaining Vertex Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
- PCA Investment Advisory Services sold 112 Vertex Pharmaceuticals shares in Q3 2023, an estimated $39.4K.
- PCA Investment Advisory Services first reported a position in Vertex Pharmaceuticals in Q2 2023 and held it in 1 quarter.
- PCA Investment Advisory Services's Vertex Pharmaceuticals position peaked at $39.4K in Q2 2023.
- 1,277 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2023.
Based on PCA Investment Advisory Services's 13F filing for Q3 2023, filed 13 Nov 2023.